Two back-to-back reports that shed light on the status of MGNREGA implementation in the country, have been released recently from the Ministry of Rural Development (MoRD). A review of MGNREGA implementation in 8 different states of India by a team of experts during the month of May this year reveals that in many of the drought affected districts, the Gram Panchayats have no work to offer under the programme. (Please click...

-Hindustan Times Ludhiana: Punjab finance minister Parminder Singh Dhindsa may have announced several perks for the agriculture sector, including provident funds for farmers, financial relief to families in which farmers committed suicides and medical insurance as part of the Budget 2016-17 for the state but several agricultural experts and farmers have pointed out all perks are futile without crop insurance. They stressed that if crop of farmers are not insured by the...

-Livemint.com Starting September, govt will usher in direct cash transfers to Aadhaar-linked bank accounts of beneficiaries in Puducherry, Chandigarh, Dadra and Nagar Haveli New Delhi: The government has decided to bite the bullet on public distribution system (PDS) reforms. Starting September, it will usher in direct cash transfers to the Aadhaar-linked bank accounts of beneficiaries in Puducherry, Chandigarh and Dadra and Nagar Haveli. In Daman and Diu, PDS benefits will be provided...

-Livemint.com   Sharp agriculture growth is a necessary factor to beat anti-incumbency The modest price hike in minimum support prices of some crops this week has been lauded as good economics. But the question that will be haunting the government is whether it has done enough to alleviate the distress in rural areas, especially when the Bihar polls later this year are seen as a litmus test for the rule of the...

-The Telegraph Regulators in several European countries are suspending marketing approval for 25 generic drugs because of concerns over the quality of data from human studies conducted by an Indian contract research company, a French medical safety agency said on Friday. Drug regulators in Belgium, France, Germany and Luxembourg have decided to suspend the marketing authorisation for the generic drugs after they discovered "irregularities" in documents relating to human studies conducted by...